Achyut Healthcare Ltd. has seen significant movement in its stock recently, with shares rising 31% over the last two weeks. The company’s last trading price on the BSE stands at ₹66.25 per share, and it currently holds a market capitalization of ₹111.47 crore.
On October 19, 2024, Achyut Healthcare announced a 4:10 bonus issue, recommending that shareholders receive four new bonus equity shares of ₹1 each for every ten existing fully paid shares of ₹1 each, pending necessary approvals. This marks the second bonus issue recommended by the company in the past year.
Additionally, Achyut Healthcare approved a 1:10 stock split, converting each ₹10 equity share into ten shares of ₹1 each, also subject to shareholder approval. Notably, the company carries a zero-debt burden, which adds to its financial appeal.
In terms of performance, Achyut Healthcare shares have shown impressive growth, with a 30% return over the past year, a 20% gain in the last year alone, and a remarkable 484% increase over the past two years. The stock’s 52-week high reached ₹71.90 (on October 17, 2024), while the 52-week low was ₹40.23 (on May 2, 2024).
As a leading pharmaceutical trading firm, Achyut Healthcare specializes in APIs, pharmaceutical products, and medical devices, leveraging innovation and technology to enhance healthcare services. The upcoming approvals for the bonus shares and stock split will be key developments to monitor in the near future.
Disclaimer: This information is for educational purposes only and should not be considered as investment advice. The performance of Achyut Healthcare Ltd shares and any related financial instruments can fluctuate, and past performance is not indicative of future results. Always conduct your own research and consult with a financial advisor before making investment decisions. The author does not hold any positions in the mentioned stock.
Leave a Reply